Condition
Adamantinomatous Craniopharyngioma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Adamantinomatous Craniopharyngioma clinical trials that are recruiting, at sites in 3 countries (most in Australia (2), United States (2), Canada (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
FOG-001 treatment for advanced or metastatic solid tumors
This study is testing a new drug called FOG-001 to see if it can help people with advanced solid tumors, especially those with certain genetic changes, when traditional treatments aren't working.
-
Using ACTEMRA to treat pediatric brain tumors
This study is testing if the drug ACTEMRA can help children and young adults with a specific type of brain tumor feel better and improve their quality of life.
Related topics
Quick answers
How many Adamantinomatous Craniopharyngioma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Australia (2 trials), United States (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.